Find clinical trials for Lung Cancer in Kansas City, KS
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Kansas City, KS, USA:
the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced non-small-cell lung...
Phase 1, Phase 2
Westwood, Kansas, United States and 7 other locations
in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who ha...
Phase 2
Kansas City, Missouri, United States and 157 other locations
of Serplulimab + chemotherapy+ concurrent radiotherapy vs chemotherapy+ concurrent radiotherapy in subjects with Limited-Stage Small Cell Lung...
Phase 3
Fairway, Kansas, United States and 128 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Westwood, Kansas, United States and 227 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that overexpress c-Met (c-Met+) best...
Phase 2
Kansas City, Kansas, United States and 252 other locations
for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung cancers are due to muta...
Phase 3
Kansas City, Kansas, United States and 152 other locations
The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of TTFields, using the NovoTTF-200T device, c...
Phase 3
Kansas City, Missouri, United States and 123 other locations
The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC patient...
Phase 3
Kansas City, Kansas, United States and 127 other locations
improved patient outcomes compared to pembrolizumab alone in patients with previously treated locally advanced or metastatic non-small cell lung...
Phase 2
Kansas City, Missouri, United States and 32 other locations
followed by durvalumab ± tremelimumab maintenance therapy versus EP alone as first-line treatment in patients with extensive-stage small-cell lung...
Phase 3
Leawood, Kansas, United States and 206 other locations
Clinical trials
Research sites
Resources
Legal